| Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541) |
|---|
| 06/13/2006 | CA2342257C Continuous hydrogenation of aromatic nitrated compounds using a catalyst with a low aluminum content |
| 06/13/2006 | CA2156764C Process for the preparation of the (-)-n-methyl-n-[4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]benzamine and its pharmaceutically acceptable salts |
| 06/08/2006 | US20060122431 Preparing levosalbutamol by assymetrically hydrogenating prochiral salbutamone in the presence of rhodium, a chiral bidentate phosphine ligand and a protic or aprotic solvent and optionally converting the product into a salt with an acid |
| 06/08/2006 | US20060122429 Preparation of optically active amines |
| 06/08/2006 | US20060122417 Method of production of (-)-(s)-3-[1-(dimethylamino)ethyl]phenyl-n-ethyl-n-methylcarbamate |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/07/2006 | CN1258527C Method for preparing aryl alkyl hydrogen peroxide |
| 06/06/2006 | US7056347 Intense, stable blue color shades can be obtained in addition to natural and purple or violet shades. |
| 06/06/2006 | CA2273789C Process to prepare tolterodine |
| 06/01/2006 | US20060116521 Method for the production of optically active 2-amino 2-chloro, 2 hydroxy or 2-alkoxy-1-alcohols |
| 06/01/2006 | US20060116364 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer |
| 05/31/2006 | EP1660433A2 Preparation and use of alkylating agents |
| 05/31/2006 | EP1660421A2 Process for preparation of (+)-p-mentha-2,8-diene-1-ol |
| 05/31/2006 | EP1251822A4 Novel coupler for use in oxidative hair dyeing |
| 05/25/2006 | US20060111572 Ligands and complex compounds containing the same |
| 05/24/2006 | EP0839162A4 Optical clarity stabilizing fatty alkyl diethanolamines |
| 05/24/2006 | CN1777569A Process for preparation of (+)-p-mentha-2,8-diene-1-ol |
| 05/24/2006 | CN1257150C Preparation method of p-aminophenol |
| 05/23/2006 | US7049469 Process for preparing (R)-salbutamol |
| 05/23/2006 | US7049446 Process for chemical reaction of amino acids and amides yielding selective conversion products |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/18/2006 | US20060106222 Aminoadamantane derivatives as therapeutic agents |
| 05/18/2006 | US20060106102 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) |
| 05/17/2006 | EP1657243A1 Procedure for the production of amino alcohols |
| 05/17/2006 | EP1657235A2 Phenethanolamine-derived haptens, immunogens and conjugates comprising them and antibodies recognising said immunogenes and conjugates |
| 05/17/2006 | CN1772726A Halofantrine preparing method |
| 05/17/2006 | CN1772725A Diamino isopropanol producing process |
| 05/16/2006 | CA2242571C Amino compounds and angiotensin iv receptor agonists |
| 05/11/2006 | WO2006049182A1 Hydroxyalkylated polyalkylenepolyamine composition, method for producing same and method for producing polyurethane resin using such hydroxyalkylated polyalkylenepolyamine composition |
| 05/11/2006 | WO2006049059A1 Metal compound, thin film-forming material, and method for producing thin film |
| 05/11/2006 | US20060100252 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid |
| 05/10/2006 | EP1654221A2 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators |
| 05/10/2006 | EP1359892B1 Primary intermediates for oxidative coloration of hair |
| 05/10/2006 | CN1771236A Optical activity bisoxazoline compound, method for producing the same and use of the same |
| 05/10/2006 | CN1255322C Preparation of iron oxide black with side product of iron reduction process to prepare amino phenol |
| 05/09/2006 | US7041703 Particularly septic shock and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained |
| 05/04/2006 | WO2006045852A1 Method of preparing phenolic amino acids from industrial products |
| 05/04/2006 | WO2006032994A3 Muscarinic receptor antagonists |
| 05/04/2006 | WO2006000441A3 Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
| 05/02/2006 | US7038087 Process for the production of optically active amino alcohols |
| 05/02/2006 | US7038044 Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates |
| 05/02/2006 | US7037938 For therapy of urinary incontinence |
| 04/27/2006 | WO2006043577A1 Method for producing phenylethanolamine compound and intermediate thereof |
| 04/27/2006 | WO2006043501A1 Fluorine-containing polymerizable monomer and polymer compound using same |
| 04/27/2006 | WO2006043418A1 Alkoxide compound, thin film-forming material and method for forming thin film |
| 04/27/2006 | US20060089497 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 04/26/2006 | EP1650184A1 Mixtures of N,N-Bis-(2-hydroxyalkyl)-4-toluidin, their preparation and use |
| 04/26/2006 | EP1648855A2 Levalbuterol hydrochloride polymorph a |
| 04/26/2006 | EP1572622B1 use of levalbuterol L-tartrate in the production of a metered dose inhaler |
| 04/26/2006 | CN1762981A 4,6-diaminoresorcinol hydrochlorate preparation method |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034176 Aminopropylphosphinic acids |
| 04/25/2006 | US7033401 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds |
| 04/20/2006 | US20060084828 Reacting (+)-limonene oxide analog with at least one amine of the in the presence of Lewis acid to form amine adducts; oxidizing the amine to form an N-oxide, pyrolysis |
| 04/20/2006 | US20060083780 liposomes; nucleic acid lipid particles; gene therapy; improved membrane fluidity |
| 04/19/2006 | EP1646606A1 2-(amino or substituted amino)-5-(substituted oxymethyl)-phenol compounds, dyeing compositions containing them, and use thereof |
| 04/19/2006 | CN1760173A Method for synthesizing o-aminophenylpropyl alcohol |
| 04/19/2006 | CN1252035C Novel chiral amino acid derivative and its synthetic method and use |
| 04/18/2006 | USRE39072 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same |
| 04/18/2006 | US7030272 β-hydroxyalkylamides process for their production and their use |
| 04/18/2006 | US7030146 Methods for treating diabetic neuropathy |
| 04/13/2006 | WO2006037950A1 Method of deprotection |
| 04/13/2006 | WO2005087752A3 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/13/2006 | US20060079715 Chemical intermediate to fingolimod, 2-(4-octylphenyl)ethyl bromide |
| 04/13/2006 | US20060079713 Novel salt forms of poorly soluble probucol esters and ethers |
| 04/12/2006 | EP1644311A2 Enantioselective synthesis of enantiomerically enriched compounds |
| 04/12/2006 | EP1418879B1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives |
| 04/12/2006 | CN1759095A N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 04/12/2006 | CN1250519C Amine derivative with K channel regulation function and its preparing process and application |
| 04/12/2006 | CN1250518C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application |
| 04/11/2006 | US7026522 Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols |
| 04/11/2006 | US7026515 Optically active amine derivatives and preparation process therefor |
| 04/11/2006 | US7026513 Manufacture of phenyl ethylamine compounds, in particular venlafaxine |
| 04/11/2006 | US7026512 Tertiary alkanolamines containing surface active alkyl groups |
| 04/11/2006 | US7026508 Succinate salt of O-desmethyl-venlafaxine |
| 04/11/2006 | US7026419 Adhesives and sealants |
| 04/11/2006 | US7026094 oxime sulfonates, e.g., 2-[Cyano-(5-n-propanesulfonyloxyimino-5H-thiophen-2-ylidene)-methyl]-benzoic acid methyl ester with high stability and good solubility in the field of chemically amplified photoresists. |
| 04/11/2006 | CA2198383C Benzene compound and pharmaceutical use thereof |
| 04/06/2006 | US20060074253 Process for the preparation of citalopram |
| 04/05/2006 | EP1641744A2 Crystalline form of b2 adrenergic receptor agonist |
| 04/05/2006 | EP1641741A1 Levalbuterol hydrochloride polymorph b |
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1537071B1 Method for the production of optically active 2-amino-,2-chloro-,2-hydroxy- or 2-alkoxy-1-alcohols |
| 04/05/2006 | EP0897747B1 Nitration or carboxylation catalysts |
| 04/05/2006 | CN1756733A Process for preparation of phenethylamine derivatives |
| 04/05/2006 | CN1249530C Alkoxyl N-hydroxy alkyl acylamine used as corrosion inhibitor remover |
| 04/04/2006 | US7022882 Peptide-free N-methyl-D aspartate receptor open channel blocker which mitigates excitotoxicity to aid in preventing neuronal cell death |
| 04/04/2006 | US7022857 Preparation of substituted aromatic compounds |
| 04/04/2006 | US7022739 Substituted 1-aminobutan-3-ol compounds |
| 03/30/2006 | WO2006032719A1 Supported-phase indicator system for the detection of sulphurated compounds of the mercaptan type and other molecules with thiol groups that produce unpleasant odours |
| 03/30/2006 | WO2006032665A1 (z)-8-cycloheptadecene-1-one used as a perfume |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/28/2006 | US7019152 Optical resolution using a racemic mixture [(1RS,2RS,4aSR,8aSR)-2-hydroxy-2,5,5,8a-tetramethyl-decahydronaphthalen-1-yl]acetic acid derivative as starting material to react with an optically actie enantiomer of 2-(methylamino)-1-phenyl-1-propanol; efficiency; synthesis of perfumery ingredient (-)-Ambrox |
| 03/28/2006 | US7019045 Amino group containing phenol |
| 03/28/2006 | US7019033 For therapy of cancer and other proliferative diseases such as inflammation, psoriasis and restenosis, as well as stroke, heart failure, and immunodeficiency disorders |
| 03/28/2006 | US7018797 Method for treating neurodegenerative disorders |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | DE102004036787A1 Verfahren zur Herstellung von alkylierten Aminen A process for the preparation of alkylated amines |
| 03/23/2006 | DE102004036664A1 Use of choline e.g. preparing a antistatically active plastic composition, decorative, transparent, surface materials and impregnation mixture for cellulose containing product such as paper and/or natural or synthetic fibers and textiles |
| 03/22/2006 | EP1636170A1 Process for preparing ethanolamine with improved colour |